Marcq en Baroeul, France

Eric Van Belle

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Ctre Hospitalier Universitaire De Lille, Laboratoire Francais Du Fractionnement Et Des Biotechnologies, Université Lille 2 - Droit Et Santé. Active years: 2019.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eric Van Belle: Innovator in Medical Composition

Introduction

Eric Van Belle is a notable inventor based in Marcq en Baroeul, France. He has made significant contributions to the field of medical science, particularly in the area of haemorrhage prevention and treatment. His innovative work has the potential to impact patient care significantly.

Latest Patents

Eric Van Belle holds a patent for the use of von Willebrand factor. This invention relates to a von Willebrand factor composition designed for the prevention and/or treatment of haemorrhage and/or bleeding in patients with mechanical circulatory support. This patent highlights his commitment to advancing medical technology and improving patient outcomes.

Career Highlights

Throughout his career, Eric has worked with esteemed institutions such as the Centre Hospitalier Universitaire de Lille and Université Lille 2 - Droit et Santé. His experience in these organizations has allowed him to collaborate with leading professionals in the medical field and contribute to groundbreaking research.

Collaborations

Eric has collaborated with notable colleagues, including Sophie Susen and Andre Vincentelli. These partnerships have fostered an environment of innovation and have led to advancements in medical treatments.

Conclusion

Eric Van Belle's contributions to medical science through his patent and collaborations demonstrate his dedication to improving healthcare. His work in developing compositions for haemorrhage treatment showcases the importance of innovation in medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…